105 related articles for article (PubMed ID: 3621222)
1. Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Yazigi R; Yordan E
Cancer Treat Rep; 1987 Sep; 71(9):873-4. PubMed ID: 3621222
[No Abstract] [Full Text] [Related]
2. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Homesley HD
Cancer Treat Rep; 1984 Dec; 68(12):1513-4. PubMed ID: 6509456
[No Abstract] [Full Text] [Related]
3. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
[No Abstract] [Full Text] [Related]
4. Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
Muss H; Bundy BN; DiSaia PJ; Twiggs LB
Cancer Treat Rep; 1986 Oct; 70(10):1231-2. PubMed ID: 3530450
[No Abstract] [Full Text] [Related]
5. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
[No Abstract] [Full Text] [Related]
6. Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
Gad-el-Mawla NM; Muggia FM; Hamza MR; El-Morsi B; Sherif M; Mansour MA; Khafagy M; El-Sebai IT
Cancer Treat Rep; 1978 Jul; 62(7):993-6. PubMed ID: 99234
[No Abstract] [Full Text] [Related]
7. Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Stehman FB; Malfetano J
Cancer Treat Rep; 1986 Sep; 70(9):1127-8. PubMed ID: 3742494
[No Abstract] [Full Text] [Related]
8. Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Given FT; Stehman FB
Am J Clin Oncol; 1990 Apr; 13(2):117-8. PubMed ID: 2316480
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Barrett RJ; Gallup DG
Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
[TBL] [Abstract][Full Text] [Related]
10. Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
Qazi R; Elson P; Khandekar JD
Cancer Treat Rep; 1982 Feb; 66(2):405-6. PubMed ID: 7055823
[No Abstract] [Full Text] [Related]
11. Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Locker GY; Lanzotti V; Khandekar JD; Sweet D; Shaw J; Bitran J; Gordon L; Krauss S; Johnson C
Cancer Treat Rep; 1986 Feb; 70(2):307-8. PubMed ID: 3948195
[No Abstract] [Full Text] [Related]
12. Phase II trial of dichloromethotrexate in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Roberts JA; Blessing JA; McGehee R; Beecham J; Homesley HD
Cancer Treat Rep; 1987 Dec; 71(12):1295-6. PubMed ID: 3690541
[No Abstract] [Full Text] [Related]
13. Phase II study of teniposide in small cell carcinoma of the lung.
Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
Thigpen T; Blessing JA; Gallup DG; Maiman M; Soper JT
Gynecol Oncol; 1995 Jun; 57(3):376-9. PubMed ID: 7774841
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix.
Slavik M; Muss H; Blessing JA
Cancer Treat Rep; 1983 Feb; 67(2):195-6. PubMed ID: 6297730
[No Abstract] [Full Text] [Related]
16. Mitoxantrone and advanced squamous cell carcinoma of the cervix: a Southwest Oncology Group Study.
Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG
Cancer Treat Rep; 1986 Apr; 70(4):527-8. PubMed ID: 3698047
[No Abstract] [Full Text] [Related]
17. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
19. Continuous-infusion vindesine in refractory carcinoma of the cervix: a phase II trial.
Kavanagh JJ; Saul PB; Gershenson DM; Copeland LJ; Wharton JT
Cancer Treat Rep; 1985 Nov; 69(11):1317-8. PubMed ID: 4092193
[No Abstract] [Full Text] [Related]
20. Teniposide in refractory ovarian cancer: a phase II study.
Sessa C; D'Incalci M; Landoni F; Colombo N; Mangioni C
Cancer Treat Rep; 1984 May; 68(5):815-6. PubMed ID: 6722838
[No Abstract] [Full Text] [Related]
[Next] [New Search]